testomax 25 mg
padagis israel pharmaceuticals ltd, israel - testosterone - gel - testosterone 25 mg/dose - testosterone - testosterone - testosterone replacement therapy for males hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.
testomax 50 mg
padagis israel pharmaceuticals ltd, israel - testosterone - gel - testosterone 50 mg/dose - testosterone and estrogen - testosterone and estrogen - testosterone replacement therapy for males hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.
suprefact 1 mg/ml solution for injection
sanofi-aventis ireland limited t/a sanofi - buserelin - solution for injection - 1 milligram(s)/millilitre - gonadotropin releasing hormone analogues; buserelin
inspra tablets 25mg
viatris private limited - eplerenone - tablet, coated - 25 mg - eplerenone 25 mg
inspra tablets 50mg
viatris private limited - eplerenone - tablet, coated - 50 mg - eplerenone 50 mg
androcur tablet 50 mg
bayer (south east asia) pte ltd - cyproterone acetate - tablet - 50 mg - cyproterone acetate 50 mg
utrogestan 200mg capsules
besins healthcare (uk) ltd - progesterone - oral capsule - 200mg
cyclodynon tablets film-coated
bionorica se - agnus castus dry extract - tablets film-coated - 4mg
utrogestan 100 mg capsules, soft
laboratoires besins international - progesterone - capsule, soft - 100 milligram(s) - progesterone
utrogestan 200
cts ltd - progesterone micronized - capsules - progesterone micronized 200 mg - progesterone - progesterone - vaginal administration: progesterone substitution for ovary deprived women in situation of total progesterone deficiency. supplementation of the luteal phase during in vitro fertilization cycles. supplementation of the luteal phase during spontaneous or induced cycles, in cases of hypofertility or primary or secondary ovarain failure, particulary through dysovulation. in cases of threatning abortion or prevention of repeated abortions due to proven luteal insufficiency. for all other progesterone indication, in the case of : adverse events due to progesterone, contraindication of the oral route of administration hepatopathy. vaginal or oral addministration: disorders related to progesterone deficit in particular menopause ( in association with estrogen therapy).